How biotechs can rethink their strategies after the market downturn


Biotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation. Insights on Life Sciences Health Care Biotechnology

A new portfolio model for biotech


An emerging model for biotech companies could disrupt the R&D landscape and open up new ways to invest, motivate teams, and shape the innovation pipeline.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What are the biotech investment themes that will shape the industry?


From 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could transform the industry.

The UK biotech sector: The path to global leadership


The United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. How is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale? Insights on Life Sciences Pharmaceuticals Medical products United Kingdom

Building a global biotech: Taking a first-time launch into international markets


Establishing an international presence with a first launch is a challenge, but learning from others’ experiences can help biotechs avoid missteps and maximize their chances of success.

Can European biotechs achieve greater scale in a fragmented landscape?


World-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe is to emerge as a leader in biotech.

CROs and biotech companies: Fine-tuning the partnership


Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment? Insights on Life Sciences Biotechnology

Using Biotech Project Management Software to Drive Value

Planview Blog

Today we’re going to look at how a global biotech company used biotech project management software to drive greater business value. Senior Director of IT Governance, Global Biotech Company. ” Senior Director of IT Governance, Global Biotech Company.

Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe

Frost & Sullivan

As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.”

Infographic: The McKinsey Biotech Innovation Index


Europe may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation Index improved by 20 percent in 2015–17 and 2018–20. Insights on Pharmaceuticals & Medical Products Biotechnology Europe

Infographic: Biotech hot spots in a fragmented European landscape


We mapped out 1,382 biotechs based in Europe and some interesting themes emerged. Insights on Pharmaceuticals & Medical Products Biotechnology

Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms

Frost & Sullivan

About Evaxion Biotech A/S (Evaxion). Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer, and vaccines against bacterial diseases and viral infections.

Infographic: Biotech in Europe: Driving the next act


How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas. Insights on Pharmaceuticals & Medical Products Biotechnology

Infographic: Biotech in Europe: Driving the next act


How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas. Insights on Life Sciences Biotechnology

Infographic: Capital landscape for European biotechs is maturing, but it continues to trail the United States


Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential to the continued growth of this sector. Insights on Pharmaceuticals & Medical Products Biotechnology Europe

The committed innovator: A conversation with Neal Gutterson of Corteva


How a biotech scientist helped transform a traditional science organization into an innovation leader. Strategy & Corporate Finance Insights

Infographic: Building the European biotech sector with world-class science and innovation


Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China. Insights on Pharmaceuticals & Medical Products Biotechnology Europe

O’Dwyer’s PR News: “The Biopharma Communications Balancing Act”

LaVoie Health Science Blog

Donna discusses what makes strategic communications and investor relations in biotech different from other industries. The communications function is often reliant on the entire strategic leadership team in a startup biotech.

Where is the Reporting Line for an Alliance Team?

Peter Simoons

This is what we most often see in pharma and biotech alliances. Last week I was asked a question about where would be the best location for an alliance & partnerships team in an organisation for reporting purposes.

Manager, Analyst & Investor Relations

LaVoie Health Science Blog

Knowledge and understanding of what drives value for biotech, platform and product companies in health as well as knowledge of the specialist investors, banks, analysts. Seeking an individual that wants to join a growing team of health and science communications experts to drive investor targeting and outreach as well as handling of investor meetings with senior management at client companies. Track investor outreach, report and guide on next steps based on feedback.

ZAGENO Applauded by Frost & Sullivan for Simplifying the Supply Chain for Life Science Research with Its e-Commerce Platform

Frost & Sullivan Manufacturing

The company provides a life science research e-commerce platform that handles purchasing transactions for suppliers and buyers, including world-renowned academic and government research facilities and global pharmaceutical and biotech companies. SAN ANTONIO, TX.

Back to BIO In Person: An Interview with Donna LaVoie, President & CEO

LaVoie Health Science Blog

DL: As an integrated communications agency serving the biotech, pharmaceutical, and affiliated health and science industry for over 20 years , we developed specific guidance for clients on how to develop and deliver highly effective corporate presentations.

A Well-Honed Message Will Give You the Edge You Need

LaVoie Health Science Blog

At the same time, the biotech and pharmaceutical industries are in the spotlight as never before as nations and companies push programs to try to develop vaccines and therapeutics for the virus faster than drugs have ever been created before.

Managing Turbulent Times and the Integrated Communication Model

LaVoie Health Science Blog

GB: Donna Lavoie founded her integrated communications agency almost 22 years ago in the firm conviction that biotech and health sciences companies are best served having their public, media, and investor relations all under one roof, from seed-stage to corporate adulthood.


LaVoie Health Science Blog

LaVoieHealthScience interns work with an innovative account team on key pharma and biotech accounts as well as assisting with agency marketing efforts. Our interns grow professionally through exposure to a wide range of corporate marketing and communications, media relations and investor relations accounts and projects.

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. Interviews with our senior practice managers about issues of important to life science innovators.

AVP/VP, PR & Media

LaVoie Health Science Blog

The ideal experience is in Biotech, Pharma, Device, MedTech, Public Health & Wellness and will contribute to agency revenue growth by retaining and organically growing the existing portfolio of clients, as well as leveraging his/her relationships and deep experience as a healthcare industry leader, to attract new clients through relationship cultivation and network development.

Mike Gaito, Global Head of Healthcare Investment Banking at J.P. Morgan talks #JPM21 going virtual, IPOs, and broader market trends for the new year

LaVoie Health Science Blog

Wainwright has announced their “Bioconnect” event will be held virtually during the same week as JPM, and the Biotech Showcase, traditionally held at the Hilton in San Francisco, is piloting a new virtual format with advance access for participants beginning as early as this November.

LaVoieHealthScience Announces Continuance of U.S. Service Marks for LHS Immersion® and The LHS Fifteen-Slide Presentation®

LaVoie Health Science Blog

LaVoie , President and CEO, said “Our LHS Immersion process and The LHS Fifteen-Slide Presentation approach are foundational elements of the fully individualized communications services we provide to help our biotech, pharma, and health science clients uncover and pursue optimal strategies to reach their business goals. Proprietary Message & Positioning Platform Defines Narrative for Health & Science Innovators.

Ep. 163 – SADA Systems COO, Dana Berg

COO Alliance

Our guest today is COO Alliance Member, Dana Berg the COO of SADA Systems. . As Chief Operating Officer, Dana Berg is driven by the singular mission of identifying and implementing innovative solutions that create competitive advantages for our customers.

5 Virtual Success Tips for Sales and Marketing Leaders


Just a few days ago, Pfizer and Biotech announced they are making headway on a vaccine that could be released by spring. As business leaders, we’re always on the lookout for success insights.

Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Leadership Award

Frost & Sullivan

It provides blood safety, clinical chemistry, companion diagnostics, custom biotech, laboratory automation and software solutions, and molecular diagnostics services. Roche is the world’s largest biotech company.

Watch: AI and the Future of Work Webinar

Partnership on AI

Watch the webinar as the assembled team of experts discuss cut through common misconceptions and highlight findings from case studies featuring three different organizations integrating AI from three different sectors (Steel, Retail Banking, and Biotech). What are the real-world impacts of AI on labor and the economy?

Paid Internship

LaVoie Health Science Blog

LaVoieHealthScience interns work with an innovative account team on key pharma and biotech accounts as well as assisting with agency marketing efforts. Hybrid, Boston, Full-Time. DESCRIPTION. LaVoieHealthScience is looking for recent college graduates interested in gaining experience in public relations and marketing in the growing life science industry. Highly-qualified College seniors with relevant experience may also be considered for immediate placement.

Vice President, Investor Relations

LaVoie Health Science Blog

A minimum of 8-15 years of experience in life science, healthcare accounts – both biotech and pharma will be important to the role and preferred. Seeking a practice builder to sit in our Boston office in Back Bay. Successful candidate will have proven people skills, with demonstrated leadership qualities, with a strong ability to take action and make things happen. This is a role for an executive who can think big but roll up his/her sleeves.

Pharmactive Earns Acclaim from Frost & Sullivan for Helping People Improve their Cognitive Functions with its Saffron-based Ingredient, Affron®

Frost & Sullivan

Based on its recent analysis of the North American market for industrial enterprise performance management, Frost & Sullivan recognizes Pharmactive Biotech Products, S.L. About Pharmactive Biotech Products, S.L. Pharmactive Biotech Products, S.L.,

Q&A: Adjusting to the Hybrid Meeting Landscape in the Health and Science Industry

LaVoie Health Science Blog

With a mixture of meetings in person and virtual, we anticipate that the cadence of meetings will be more efficient with JP Morgan and the Biotech Showcase family of events meeting in person that week and the Needham Growth Conference and HC Wainwright Bioconnect Conferences meeting virtually.

7 Reasons Why PPD’s Acquisition will Help TMO Gain a Top Spot in the CRO Market

Frost & Sullivan

The expanded portfolio will help build long-term relationships with small and mid-sized pharma and biotech sponsors due to increased engagement early on in the drug development process.

Atos: Channel Profile & Services

Channel Insider

Atos is a global digital solutions company offering industry-recognized solutions for cybersecurity, digital workplaces, consulting, and managed services.

Why nano-capitalization public companies should evaluate strategic alternatives, including going private transactions

The Capital Alliance Blog

It might make sense for a biotech company, for example, that is researching a new drug and needs ready access to capital. By Russell Tolander. Managing Director. Nano-capitalization public companies, those with a valuation of less than $50 million, have fewer active buyers interested in them in today’s public markets, due to existing trends such as investors’ favoritism toward large companies, technology startups and disruptive or innovative business models (think Uber, Lyft, Amazon).